Cargando…
Low‐molecular weight heparin prevents portal vein system thrombosis after splenectomy: a systematic review and meta‐analysis
BACKGROUND: The aim of this study was to evaluate the safety and efficacy of low‐molecular weight heparin (LMWH) in the prevention of portal vein system thrombosis (PVST) after splenectomy. METHODS: A systematic search was performed using PubMed, EMBASE, Springer and Cochrane Library databases to sc...
Autores principales: | Yang, Ming, Liu, Jinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818250/ https://www.ncbi.nlm.nih.gov/pubmed/32338419 http://dx.doi.org/10.1111/ans.15865 |
Ejemplares similares
-
Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension
por: Wei, Qiang, et al.
Publicado: (2022) -
Rivaroxaban versus low-molecular weight heparin plus warfarin prevents portal vein system thrombosis after splenectomy and pericardial devascularization: A randomized clinical trial
por: Yao, Wei, et al.
Publicado: (2021) -
Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis
por: Liao, Zheng, et al.
Publicado: (2023) -
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?
por: Licinio, Raffaele, et al.
Publicado: (2014) -
Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
por: Han, Ji Min, et al.
Publicado: (2023)